Skip to main content

Acurx Pharmaceuticals, Inc.

ACXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001736243

No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Acurx Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
22
−2 vs. Q2 2024
Shares held
1.27M
+87.4K (+7.4%) vs. Q2 2024
Total value
$2.41M
−$240.6K (−9.1%) vs. Q2 2024
New holders
2
4 more added
Sold out
4
6 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 22 institutions
Q1 2021: 0 institutionsQ2 2021: 3 institutionsQ3 2021: 8 institutionsQ4 2021: 11 institutionsQ1 2022: 9 institutionsQ2 2022: 12 institutionsQ3 2022: 14 institutionsQ4 2022: 14 institutionsQ1 2023: 12 institutionsQ2 2023: 13 institutionsQ3 2023: 18 institutionsQ4 2023: 23 institutionsQ1 2024: 26 institutionsQ2 2024: 25 institutionsQ3 2024: 22 institutionsQ4 2024: 26 institutionsQ1 2025: 24 institutionsQ2 2025: 32 institutionsQ3 2025: 16 institutionsQ4 2025: 18 institutionsQ1 2026: 21 institutionsQ2 2026: 18 institutions
Value heldQ3 2024: $2.41M
Q1 2021: $0Q2 2021: $163.0KQ3 2021: $332.0KQ4 2021: $455.3KQ1 2022: $1.15MQ2 2022: $1.43MQ3 2022: $4.66MQ4 2022: $5.27MQ1 2023: $1.86MQ2 2023: $3.94MQ3 2023: $1.32MQ4 2023: $4.18MQ1 2024: $3.05MQ2 2024: $2.71MQ3 2024: $2.41MQ4 2024: $1.15MQ1 2025: $1.36MQ2 2025: $1.33MQ3 2025: $241.5KQ4 2025: $345.2KQ1 2026: $674.2KQ2 2026: $185.5K
Institutions holding ACXP and their total value by quarter
QuarterHoldersValue
Q2 202618$185.5K
Q1 202621$674.2K
Q4 202518$345.2K
Q3 202516$241.5K
Q2 202532$1.33M
Q1 202524$1.36M
Q4 202426$1.15M
Q3 202422$2.41M
Q2 202425$2.71M
Q1 202426$3.05M
Q4 202323$4.18M
Q3 202318$1.32M
Q2 202313$3.94M
Q1 202312$1.86M
Q4 202214$5.27M
Q3 202214$4.66M
Q2 202212$1.43M
Q1 20229$1.15M
Q4 202111$455.3K
Q3 20218$332.0K
Q2 20213$163.0K
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Acurx Pharmaceuticals, Inc.; share changes are against Q2 2024.

Institutions holding ACXP in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc529,349$1.01M0.00%+37,662+7.7%Added
Prospect Financial Services LLC295,075$560.6K0.35%+16,975+6.1%Added
Geode Capital Management, LLC146,500$278.4K0.00%+16,485+12.7%Added
Morgan Stanley46,201$87.8K0.00%−200−0.4%Reduced
LPL Financial LLC44,780$85.1K0.00%−8,955−16.7%Reduced
State Street Corp43,466$82.6K0.00%00.0%Unchanged
BlackRock, Inc.28,535$54.2K0.00%+28,535New
Northern Trust Corp27,286$51.8K0.00%00.0%Unchanged
NBC Securities, Inc.19,000$36.0K0.00%00.0%Unchanged
TD Waterhouse Canada Inc.18,656$35.6K0.00%00.0%Unchanged
StoneX Group Inc.17,800$33.8K0.00%+17,800New
Advisor Group Holdings, Inc.14,210$27.0K0.00%−1,000−6.6%Reduced
Patriot Financial Group Insurance Agency, LLC10,385$19.7K0.00%00.0%Unchanged
Tocqueville Asset Management L.P.10,000$19.0K0.00%00.0%Unchanged
Semmax Financial Advisors Inc.5,879$10.9K0.00%00.0%Unchanged
Cornerstone Planning Group LLC3,344$6.49K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)2,065$3.92K0.00%−2,073−50.1%Reduced
Northwestern Mutual Wealth Management Co1,636$3.11K0.00%00.0%Unchanged
Simplex Trading, LLC1,161$2.00K0.00%−1,757−60.2%Reduced
GPS Wealth Strategies Group, LLC500$9500.00%00.0%Unchanged
Group One Trading, L.P.173$3290.00%−5,049−96.7%Reduced
Bank of America Corp113$2150.00%+8+7.6%Added
Cambridge Investment Research Advisors, Inc.0$00.00%−10,000−100.0%Sold out
UBS Group AG0$00.00%−881−100.0%Sold out
Citadel Advisors LLC0$00.00%−64−100.0%Sold out
Royal Bank of Canada0$00.00%−132−100.0%Sold out
BlackRock Inc.––––Not filed